Tag: vaccine
Pfizer aims to ship COVID vaccine doses ‘within hours’ of regulatory...
After Pfizer’s leading COVID-19 vaccine turned in strong data in a late-stage trial, the company planned to submit its program to U.S. authorities for an emergency use authorization “within...
Moderna’s COVID vaccine is stable in refrigerators for 30 days, easing...
A week after Pfizer posted impressive early coronavirus vaccine efficacy numbers, Moderna took the spotlight early Monday with impressive findings of its own. But separate from...
J&J tops list of healthcare supply chains amid COVID vaccine effort—and...
With a range of COVID-19 vaccine candidates nearing the finish line, more eyes are turning to the strength of drugmakers' supply chains to meet...
Moderna, now wrapped on phase 3 enrollment, touts diversity of vaccine...
Moderna is one step closer to a COVID-19 vaccine. Racing ahead with its candidate, mRNA-1273, the biotech has now finished enrolling the 30,000 participants...
Pfizer could haul in $3.5B in 2021 from COVID-19 vaccine: analyst
Among the ever-growing collection of biopharma companies developing COVID-19 vaccines, Pfizer is emerging as a clear frontrunner—even after CEO Albert Bourla vowed not to...
Planes, trucks and ultracold boxes: Pfizer preps massive COVID vaccine distribution...
As Pfizer’s COVID-19 vaccine comes into the home stretch on the R&D side, the drugmaker is scaling up an ambitious supply chain and distribution system aimed at...
What will FDA’s experts review at their first COVID-19 vaccine hearing?...
The countdown to the FDA's first coronavirus vaccine hearing has begun.
More than seven months into the COVID-19 pandemic, with several vaccines in late-stage testing...
Contract manufacturer Cytiva tasked with COVID-19 vaccine work as part of...
With the U.S. working at a rapid clip to scale capacity for a range of COVID-19 vaccines and therapeutics, stateside manufacturers are snagging big...
FiercePharmaAsia—COVID-19 data from China-made antibody, vaccine; Takeda-Arrowhead $1B RNAi collab
As President Donald Trump endorses Regeneron's COVID-19 antibody cocktail, Eli Lilly reported positive phase 2 results for its two-drug prospect, made in collaboration with...
Moderna won’t enforce COVID-19 vaccine patents during pandemic
Moderna, a biotech advancing one of the leading COVID-19 vaccine candidates, has faced questions for several months over its patents and intellectual property. Responding...